Ghrelin as potential new pathway toward medication development for alcohol use disorder: Recent clinical data

The rewarding properties of natural and chemical reinforcers are mediated via multiple and complex pathways in the brain. There is an underlying disruption in reward processing in animal models of and individuals with addictions. This raises the possibility that endocrine signals from the gut traditionally known to regulate food intake may play an important role in reward regulation as well as in development of drug dependence. Dr. Leggio will present recent clinical data suggesting that GLP-1 and ghrelin represent potential new pathways toward medication development for alcohol use disorder.
Source: Alcohol - Category: Addiction Authors: Source Type: research